4P-Pharma
4P-Pharma's Overview
4P-Pharma is a clinical-stage biotechnology company headquartered in Lille, France, dedicated to the research and development of novel, first-in-class curative therapies for severe diseases that currently lack effective treatments. The company focuses on a 'drug regeneration' strategy, identifying and developing promising drug candidates to address high unmet medical needs in areas such as musculoskeletal disorders (e.g., osteoarthritis) and liver diseases (e.g., NASH). Leveraging a strong scientific expertise and a network of academic and industry partners, 4P-Pharma aims to accelerate the delivery of innovative medicines to patients worldwide.
Where is 4P-Pharma's Headquarters?
HQ Function
Serves as the central hub for 4P-Pharma's research and development, clinical operations, strategic planning, and corporate administration.
Notable Features:
Located within the prestigious Institut Pasteur de Lille, providing access to a rich ecosystem for biomedical research, advanced laboratory facilities, and collaborative workspaces.
Work Culture:
A dynamic, science-driven, and collaborative environment focused on innovation, scientific rigor, and agility. The culture encourages a strong commitment to addressing unmet medical needs and improving patient outcomes.
HQ Significance:
The strategic location at Institut Pasteur de Lille offers significant advantages, including access to cutting-edge research infrastructure, a pool of highly skilled talent, and a vibrant network of scientific and clinical collaborators essential for advancing their drug development pipeline.
Values Reflected in HQ: The headquarters' setting and operations reflect 4P-Pharma's core values of innovation, scientific excellence, collaboration, and a patient-centric approach to developing transformative therapies.
Location:
4P-Pharma operates with a global vision, focused on developing therapies for worldwide patient populations. The company establishes international collaborations for research and development, conducts clinical trials in multiple regions, and aims for global regulatory approvals. Its U.S. subsidiary, 4Moving Biotech Inc., anchors its presence and operations in North America, particularly for advancing clinical programs and engaging with regulatory authorities and partners in this key market.
Street Address:
Institut Pasteur de Lille, 1 Rue du Professeur Calmette
City:
Lille
State/Province:
Hauts-de-France
Country:
France
4P-Pharma's Global Presence
Cambridge, MA, USA
Address: Cambridge Innovation Center (CIC), Cambridge, MA, USA (Representative Location)
To facilitate engagement with the U.S. Food and Drug Administration (FDA), manage U.S.-based clinical trial sites, and foster partnerships within the significant North American pharmaceutical and biotech ecosystem.
Buying Intent Signals for 4P-Pharma
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Executive Team of 4P-Pharma
As of April 2025, 4P-Pharma' leadership includes:
Investors of 4P-Pharma
4P-Pharma has been backed by several prominent investors over the years, including:
Executive New Hires/Exits in the Last 12 Months
In the last 12-18 months, 4P-Pharma has strategically reinforced its executive team with key appointments to drive its pipeline advancement and business development efforts. No major executive departures have been publicly announced during this period.
New Appointments:
Technology (Tech Stack) used by 4P-Pharma
Discover the tools 4P-Pharma uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
4P-Pharma Email Formats and Examples
While 4P-Pharma's exact email format is not publicly confirmed, common patterns for companies in the biotechnology sector include [first_initial][last] or [first].[last]@[domain]. For example, 'jdoe@4p-pharma.com' or 'john.doe@4p-pharma.com'.
[first_initial][last]@4p-pharma.com
Format
thieu@4p-pharma.com
Example
75%
Success rate
News and media
4P-Pharma Press Release • February 27, 2024
4P-Pharma Secures €15 Million in Series B Funding to Advance Clinical Pipeline in Osteoarthritis and NASH
4P-Pharma announced the successful completion of a €15 million Series B financing round. The funding was led by AdBio partners and Cemag Invest, with participation from existing investors. These funds will be used to advance the clinical development of its lead candidates, 4P004 for Osteoarthritis and 4P020 for NASH....more
4P-Pharma Press Release • July 11, 2023
4P-Pharma's Lead Candidate 4P004 (Lasareparagin) Receives FDA Fast Track Designation for Osteoarthritis
The U.S. Food and Drug Administration (FDA) granted Fast Track designation to 4P004 (Lasareparagin), 4P-Pharma's first-in-class disease-modifying drug candidate for knee osteoarthritis. This designation underscores its potential to address a significant unmet medical need....more
4P-Pharma Press Release • February 7, 2023
4P-Pharma Strengthens Its Management Team with the Appointment of Thomas Hieu, PhD, as Chief Business Officer (CBO)
4P-Pharma announced the appointment of Thomas Hieu, PhD, as its new Chief Business Officer. Dr. Hieu will be responsible for leading the company's business development, licensing, and strategic alliance activities to support its growth and pipeline....more
Highperformr’s free tools for company research
Explore Employees by Region or Country
See where a company’s workforce is located, by country or region.
View Funding Details
View past and recent funding rounds with amounts and investors.
Understand Revenue Insights
Understand company revenue estimates and financial scale.
Track Active Job Openings
Track active roles and hiring trends to spot growth signals.
Review Product and Offerings
Discover what a company offers—products, platforms, and solutions.
Get SIC or NAICS Codes
Get the company’s official SIC and NAICS classifications.
Analyze Website Traffic Trends
Analyze visitor volume, engagement, and top traffic sources.
Discover Social Profiles and Engagement
Explore LinkedIn, Twitter, and other active social profiles.
Identify Top Competitors
Identify top competitors based on similar business traits.
Research and Discover Companies with Highperformr — Smarter, Faster
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
- Track intent signals to find buyers who are actively in-market
- Enrich contacts and companies instantly, no need to switch tools
- Automate workflows to stay ahead of every change
- Connect your CRM & tools for seamless data sync and activation
Thousands of companies, including 4P-Pharma, are just a search away.